Safe administration of oral etoposide after hypersensitivity reaction to intravenous etoposide.
Siderov
J
J
Zalcberg
J
J
D000368:Aged; D004342:Drug Hypersensitivity / Q000209:etiology*; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects*; D005079:Excipients / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007275:Injections, Intravenous
D005079:Excipients; D005047:Etoposide